Company profile: BioFluidica
1.1 - Company Overview
Company description
- Provider of a biotechnology diagnostic platform and automated liquid biopsy microfluidic system to isolate and enrich rare biomarkers—circulating tumor cells, exosomes, and trophoblasts—from body fluids; offers exosome and CTC isolation for research and cbNIPT, plus the B³ Blood Collection Tube for room-temperature whole blood shipping with buffer to inhibit micro-clotting.
Products and services
- LiquidScan: A fully automated, microfluidic-based system that isolates and enriches rare cells and exosomes from liquid biopsy samples using antibody-surfaced chips
- CTC Isolation: An analytical-grade offering that isolates circulating tumor cells (CTCs) from body fluids to enable insights into disease onset, transitions, and ongoing monitoring
- Fetal Cell Isolation (Trophoblasts): A cbNIPT-focused process that captures circulating trophoblasts from pregnant women’s blood for non-invasive prenatal screening to identify genetic abnormalities
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BioFluidica
Pivot Bio
HQ: United States
Website
- Description: Provider of microbial nitrogen solutions for crop nutrition, including Pivot Bio PROVEN® 40 for corn and RETURN® for wheat and small grains, delivering steady nitrogen at the root on-seed or in-furrow; the N-OVATOR™ program that rewards reduced synthetic fertilizer use; and NLIGHTEN®, an in-furrow tank system for precise microbial nitrogen delivery with equipment reimbursement.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pivot Bio company profile →
Bode Technology
HQ: United States
Website
- Description: Provider of forensic DNA analysis products and services for government agencies, serving the law enforcement and identification markets. Offers state-of-the-art human DNA analysis and innovative DNA collection products, with services including high-throughput DNA testing, casework analysis, and missing person identification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bode Technology company profile →
Cartana
HQ: Sweden
Website
- Description: Provider of in situ sequencing (ISS) technology to map gene expression in brain tissue, enabling simultaneous analysis of hundreds of genes across all cells in a tissue while preserving tissue morphology, with high sensitivity and throughput.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cartana company profile →
Lentigen Technology
HQ: United States
Website
- Description: Provider of gene delivery technologies and CDMO services for cell and gene therapy products, offering lentiviral vector technology for therapeutic, vaccine, and research applications; lentiviral vector design, evaluation, and scalable manufacturing; process development and clinical manufacturing; assay development via automated flow cytometry; and regulatory support from pre-IND to approval.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lentigen Technology company profile →
Biotheranostics
HQ: United States
Website
- Description: Provider of commercial-stage molecular diagnostics, delivering diagnostic, prognostic, and predictive tests that support physicians in treating cancer, including Breast Cancer Index, a genomic test predicting benefit of extended endocrine therapy in HR+, early-stage breast cancer, and CancerTYPE ID, a gene expression assay identifying tumor type/subtype in metastatic cancer with unknown or unclear diagnoses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biotheranostics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BioFluidica
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BioFluidica
2.2 - Growth funds investing in similar companies to BioFluidica
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BioFluidica
4.2 - Public trading comparable groups for BioFluidica
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →